Oral ketoconazole (Nizoral, etc) will continue to fall out of favor for fungal infections

Oral ketoconazole (Nizoral, etc) will continue to fall out of favor for fungal infections...due to stronger labeling restrictions.

It's no longer approved for skin infections due to the risk of hepatotoxicity, adrenal insufficiency, and serious drug interactions.

And it will probably be withdrawn in Europe.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote